• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型 FSH 受体(I423T)突变影响受体激活并导致原发性卵巢功能衰竭。

A Novel Mutation in the FSH Receptor (I423T) Affecting Receptor Activation and Leading to Primary Ovarian Failure.

机构信息

Red de Apoyo a la Investigación, National University of Mexico-Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.

Department of Reproductive Biology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.

出版信息

J Clin Endocrinol Metab. 2021 Jan 23;106(2):e534-e550. doi: 10.1210/clinem/dgaa782.

DOI:10.1210/clinem/dgaa782
PMID:33119067
Abstract

CONTEXT

Follicle-stimulating hormone (FSH) plays an essential role in gonadal function. Loss-of-function mutations in the follicle-stimulating hormone receptor (FSHR) are an infrequent cause of primary ovarian failure.

OBJECTIVE

To analyze the molecular physiopathogenesis of a novel mutation in the FSHR identified in a woman with primary ovarian failure, employing in vitro and in silico approaches, and to compare the features of this dysfunctional receptor with those shown by the trafficking-defective D408Y FSHR mutant.

METHODS

Sanger sequencing of the FSHR cDNA was applied to identify the novel mutation. FSH-stimulated cyclic adenosine monophosphate (cAMP) production, ERK1/2 phosphorylation, and desensitization were tested in HEK293 cells. Receptor expression was analyzed by immunoblotting, receptor-binding assays, and flow cytometry. Molecular dynamics simulations were performed to determine the in silico behavior of the mutant FSHRs.

RESULTS

A novel missense mutation (I423T) in the second transmembrane domain of the FSHR was identified in a woman with normal pubertal development but primary amenorrhea. The I423T mutation slightly impaired plasma membrane expression of the mature form of the receptor and severely impacted on cAMP/protein kinase A signaling but much less on β-arrestin-dependent ERK1/2 phosphorylation. Meanwhile, the D408Y mutation severely affected membrane expression, with most of the FSH receptor located intracellularly, and both signal readouts tested. Molecular dynamics simulations revealed important functional disruptions in both mutant FSHRs, mainly the loss of interhelical connectivity in the D408Y FSHR.

CONCLUSIONS

Concurrently, these data indicate that conformational differences during the inactive and active states account for the distinct expression levels, differential signaling, and phenotypic expression of the I423T and D408Y mutant FSHRs.

摘要

背景

卵泡刺激素(FSH)在性腺功能中起着至关重要的作用。卵泡刺激素受体(FSHR)的功能丧失性突变是原发性卵巢功能衰竭的一个罕见原因。

目的

运用体外和计算机模拟方法分析在一名原发性卵巢功能衰竭女性中发现的 FSHR 新型突变的分子病理生理学,并将这种功能失调的受体与表现出转运缺陷的 D408Y FSHR 突变体的特征进行比较。

方法

应用 Sanger 测序对 FSHR cDNA 进行测序,以鉴定新型突变。在 HEK293 细胞中测试 FSH 刺激的环磷酸腺苷(cAMP)产生、ERK1/2 磷酸化和脱敏。通过免疫印迹、受体结合测定和流式细胞术分析受体表达。进行分子动力学模拟以确定突变 FSHR 的计算机行为。

结果

在一名青春期正常发育但原发性闭经的女性中发现 FSHR 的第二个跨膜结构域中的新型错义突变(I423T)。I423T 突变轻微损害成熟形式的受体的质膜表达,严重影响 cAMP/蛋白激酶 A 信号传导,但对β-arrestin 依赖性 ERK1/2 磷酸化的影响较小。同时,D408Y 突变严重影响膜表达,大部分 FSH 受体位于细胞内,两种信号转导均受到影响。分子动力学模拟揭示了这两种突变 FSHR 中的重要功能障碍,主要是 D408Y FSHR 中螺旋间连接的丧失。

结论

同时,这些数据表明,在无活性和活性状态下的构象差异解释了 I423T 和 D408Y 突变 FSHR 的不同表达水平、信号转导差异和表型表达。

相似文献

1
A Novel Mutation in the FSH Receptor (I423T) Affecting Receptor Activation and Leading to Primary Ovarian Failure.一种新型 FSH 受体(I423T)突变影响受体激活并导致原发性卵巢功能衰竭。
J Clin Endocrinol Metab. 2021 Jan 23;106(2):e534-e550. doi: 10.1210/clinem/dgaa782.
2
A novel follicle-stimulating hormone receptor mutation causing primary ovarian failure: a fertility application of whole exome sequencing.一种导致原发性卵巢功能衰竭的新型促卵泡激素受体突变:全外显子组测序在生育方面的应用
Hum Reprod. 2016 Apr;31(4):905-14. doi: 10.1093/humrep/dew025. Epub 2016 Feb 23.
3
New natural inactivating mutations of the follicle-stimulating hormone receptor: correlations between receptor function and phenotype.促卵泡激素受体新的天然失活突变:受体功能与表型之间的相关性
Mol Endocrinol. 1999 Nov;13(11):1844-54. doi: 10.1210/mend.13.11.0370.
4
A novel homozygous mutation in the FSHR gene is causative for primary ovarian insufficiency.FSHR基因中的一种新型纯合突变是原发性卵巢功能不全的病因。
Fertil Steril. 2017 Dec;108(6):1050-1055.e2. doi: 10.1016/j.fertnstert.2017.09.010. Epub 2017 Nov 20.
5
Preferential β-arrestin signalling at low receptor density revealed by functional characterization of the human FSH receptor A189 V mutation.通过对人促卵泡激素受体 A189 V 突变的功能特征分析揭示低受体密度下的优先β-arrestin 信号转导
Mol Cell Endocrinol. 2011 Jan 1;331(1):109-18. doi: 10.1016/j.mce.2010.08.016. Epub 2010 Aug 27.
6
Extracellular loop 3 substitutions K589N and A590S in FSH receptor increase FSH-induced receptor internalization and along with S588T substitution exhibit impaired ERK1/2 phosphorylation.细胞外环 3 上的 K589N 和 A590S 取代以及 FSH 受体上的 S588T 取代增加了 FSH 诱导的受体内化,并表现出 ERK1/2 磷酸化受损。
Arch Biochem Biophys. 2018 Dec 1;659:57-65. doi: 10.1016/j.abb.2018.09.011. Epub 2018 Sep 14.
7
Novel FSHR variants causing female resistant ovary syndrome.导致女性抵抗卵巢综合征的新型 FSHR 变体。
Mol Genet Genomic Med. 2020 Feb;8(2):e1082. doi: 10.1002/mgg3.1082. Epub 2019 Dec 12.
8
Molecular analysis of a mutated FSH receptor detected in a patient with spontaneous ovarian hyperstimulation syndrome.对一名患有自发性卵巢过度刺激综合征患者检测到的突变促卵泡激素受体进行分子分析。
PLoS One. 2013 Sep 13;8(9):e75478. doi: 10.1371/journal.pone.0075478. eCollection 2013.
9
Novel FSHR mutations in Han Chinese women with sporadic premature ovarian insufficiency.在中国汉族散发性卵巢早衰女性中发现的新型 FSHR 突变。
Mol Cell Endocrinol. 2019 Jul 15;492:110446. doi: 10.1016/j.mce.2019.05.005. Epub 2019 May 9.
10
Rescue of Cell Surface Expression and Signaling of Mutant Follicle-Stimulating Hormone Receptors.突变卵泡刺激素受体的细胞表面表达和信号转导的挽救。
Endocrinology. 2021 Dec 1;162(12). doi: 10.1210/endocr/bqab134.

引用本文的文献

1
Advances in Contraceptive Vaccine Development: A Comprehensive Review.避孕疫苗研发进展:全面综述
Vaccines (Basel). 2025 Jun 26;13(7):692. doi: 10.3390/vaccines13070692.
2
The roles of MAPK signaling pathway in ovarian folliculogenesis.丝裂原活化蛋白激酶(MAPK)信号通路在卵巢卵泡发生中的作用。
J Ovarian Res. 2025 Jul 14;18(1):152. doi: 10.1186/s13048-025-01737-9.
3
Ligand-Induced Biased Activation of GPCRs: Recent Advances and New Directions from In Silico Approaches.G蛋白偶联受体的配体诱导偏向性激活:计算机模拟方法的最新进展与新方向
Molecules. 2025 Feb 25;30(5):1047. doi: 10.3390/molecules30051047.
4
Recent Applications of In Silico Approaches for Studying Receptor Mutations Associated with Human Pathologies.近年来,基于计算机的方法在研究与人类疾病相关的受体突变中的应用。
Molecules. 2024 Nov 13;29(22):5349. doi: 10.3390/molecules29225349.
5
An overview of different methods to establish a murine premature ovarian failure model.建立小鼠卵巢早衰模型的不同方法概述。
Animal Model Exp Med. 2024 Dec;7(6):835-852. doi: 10.1002/ame2.12477. Epub 2024 Sep 1.
6
Genetic insights into the complexity of premature ovarian insufficiency.遗传视角下探讨卵巢早衰的复杂性。
Reprod Biol Endocrinol. 2024 Aug 2;22(1):94. doi: 10.1186/s12958-024-01254-2.
7
Tracking conformational transitions of the gonadotropin hormone receptors in a bilayer of (SDPC) poly-unsaturated lipids from all-atom molecular dynamics simulations.从全原子分子动力学模拟中追踪双层(SDPC)多不饱和脂质中促性腺激素受体的构象转变。
PLoS Comput Biol. 2024 Jan 11;20(1):e1011415. doi: 10.1371/journal.pcbi.1011415. eCollection 2024 Jan.
8
Selected Genetic Factors Associated with Primary Ovarian Insufficiency.与原发性卵巢功能不全相关的部分遗传因素。
Int J Mol Sci. 2023 Feb 23;24(5):4423. doi: 10.3390/ijms24054423.
9
The serum follicle stimulating hormone-to-luteinizing hormone ratios can predict assisted reproductive technology outcomes in women undergoing gonadotropin releasing hormone antagonist protocol.血清卵泡刺激素与黄体生成素比值可预测接受促性腺激素释放激素拮抗剂方案的女性的辅助生殖技术结局。
Front Endocrinol (Lausanne). 2023 Jan 30;14:1093954. doi: 10.3389/fendo.2023.1093954. eCollection 2023.
10
Identification and characterization of novel compound heterozygous variants in causing primary ovarian insufficiency with resistant ovary syndrome.鉴定并分析导致原发卵巢功能不全伴抵抗卵巢综合征的新型复合杂合变异。
Front Endocrinol (Lausanne). 2023 Jan 10;13:1013894. doi: 10.3389/fendo.2022.1013894. eCollection 2022.